Le Lézard
Classified in: Health
Subject: MRR

Surge in Surgeries Drives the Global Mannequin-Based Simulation Market to New Heights by 2030


DUBLIN, Sept. 26, 2023 /PRNewswire/ -- The "Mannequin-Based Simulation - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Research_and_Markets_Logo

The global market for Mannequin-Based Simulation is experiencing significant growth, with an estimated value of US$1.2 billion in 2022. This market is projected to reach a substantial size of US$5.6 billion by 2030, reflecting a robust compound annual growth rate (CAGR) of 21% during the period from 2022 to 2030.

Patient Simulators, a key segment within the Mannequin-Based Simulation market, are expected to grow at a CAGR of 20.4% and reach a market value of US$3.8 billion by the end of the analysis period. Additionally, the Other Product Types segment is estimated to experience even higher growth, with a projected CAGR of 22.4% over the next eight years.

Regionally, the United States is a significant market, with an estimated value of US$530.1 million in 2022. China, the world's second-largest economy, is expected to see rapid growth, reaching a projected market size of US$347.4 million by 2030, with a remarkable CAGR of 26.5% during the forecast period. Other noteworthy geographic markets include Japan and Canada, both forecasted to grow at approximately 16.8% and 19.7% CAGR, respectively, from 2022 to 2030. Germany, within Europe, is also expected to achieve substantial growth, with a CAGR of approximately 19.7%.

This comprehensive research report provides in-depth insights into the global Mannequin-Based Simulation market, focusing on patient simulators and other product types. It offers a detailed analysis of the competitive landscape, enabling businesses to formulate effective strategies for the future. Moreover, the report provides extensive coverage of geographic markets, including the United States, China, Japan, Canada, and Europe, highlighting their respective growth trajectories and opportunities.

With access to digital archives, online collaborative updates, and complimentary updates for one year, this report is an invaluable resource for investors and businesses seeking to navigate and capitalize on the growth of the Mannequin-Based Simulation market in the coming years.

Select Competitors (Total 55 Featured)

These featured companies are significant players in the Mannequin-Based Simulation market, contributing to its growth and innovation. Please note that this list is not exhaustive, as the market includes numerous other players offering various products and services in this field.

What`s New?

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/hnjzsn

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

SOURCE Research and Markets


These press releases may also interest you

15 fév 2025
Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCEtm (60mg pre-filled syringe) and XBRYKtm (120mg vial), denosumab biosimilars referencing Prolia and Xgeva ? formerly referred...

15 fév 2025
Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today presented new data for casdatifan, a HIF-2a inhibitor with...

15 fév 2025
Product: Fried Falafel with Tahini Sauce Issue: Food - Allergen - Peanut Distribution:       Alberta                           Newfoundland and Labrador                           Ontario See the affected products and product photos for this recall...

15 fév 2025
Exelixis, Inc. today announced final results from the phase 3 CheckMate -9ER pivotal trial evaluating CABOMETYX® (cabozantinib) in combination with Opdivo® (nivolumab) versus sunitinib for patients with previously untreated advanced renal cell...

15 fév 2025
For children with high threshold peanut allergy, oral immunotherapy using store-bought and home-measured peanut products provided significantly higher rates of desensitization compared to peanut avoiders, according to new research being presented at...

15 fév 2025
LifeNet Health proudly announces the launch of OraGen®, the first viable dental bone allograft comprised of cryopreserved corticocancellous bone containing endogenous lineage-committed bone cells combined with demineralized bone matrix. This unique...



News published on and distributed by: